[DPHARMA] YoY TTM Result on 30-Sep-2013 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
19-Nov-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Sep-2013 [#3]
Profit Trend
QoQ- 1.15%
YoY- 14.52%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 328,308 232,663 171,671 152,048 132,969 137,291 129,092 16.81%
PBT 42,709 46,157 41,729 40,017 34,133 35,500 35,413 3.16%
Tax -9,379 -8,786 -7,856 -9,845 -7,787 -6,509 -7,514 3.76%
NP 33,330 37,371 33,873 30,172 26,346 28,991 27,899 3.00%
-
NP to SH 34,022 34,569 33,873 30,172 26,346 28,991 27,899 3.35%
-
Tax Rate 21.96% 19.04% 18.83% 24.60% 22.81% 18.34% 21.22% -
Total Cost 294,978 195,292 137,798 121,876 106,623 108,300 101,193 19.50%
-
Net Worth 451,913 268,530 187,531 179,017 167,991 162,353 148,494 20.36%
Dividend
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Div 8,084 25,710 24,291 20,128 18,318 5,014 22,910 -15.92%
Div Payout % 23.76% 74.38% 71.71% 66.71% 69.53% 17.30% 82.12% -
Equity
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Net Worth 451,913 268,530 187,531 179,017 167,991 162,353 148,494 20.36%
NOSH 278,959 278,959 138,912 138,773 138,836 138,763 138,779 12.32%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin 10.15% 16.06% 19.73% 19.84% 19.81% 21.12% 21.61% -
ROE 7.53% 12.87% 18.06% 16.85% 15.68% 17.86% 18.79% -
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 117.69 139.50 123.58 109.57 95.77 98.94 93.02 3.99%
EPS 12.20 20.73 24.38 21.74 18.98 20.89 20.10 -7.97%
DPS 2.90 15.42 17.50 14.50 13.20 3.61 16.50 -25.13%
NAPS 1.62 1.61 1.35 1.29 1.21 1.17 1.07 7.15%
Adjusted Per Share Value based on latest NOSH - 138,773
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 34.13 24.19 17.85 15.81 13.82 14.27 13.42 16.81%
EPS 3.54 3.59 3.52 3.14 2.74 3.01 2.90 3.37%
DPS 0.84 2.67 2.53 2.09 1.90 0.52 2.38 -15.92%
NAPS 0.4698 0.2792 0.195 0.1861 0.1746 0.1688 0.1544 20.35%
Price Multiplier on Financial Quarter End Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 -
Price 2.06 2.72 3.17 2.55 2.36 2.10 2.44 -
P/RPS 1.75 1.95 2.57 2.33 2.46 2.12 2.62 -6.49%
P/EPS 16.89 13.12 13.00 11.73 12.44 10.05 12.14 5.65%
EY 5.92 7.62 7.69 8.53 8.04 9.95 8.24 -5.35%
DY 1.41 5.67 5.52 5.69 5.59 1.72 6.76 -22.97%
P/NAPS 1.27 1.69 2.35 1.98 1.95 1.79 2.28 -9.28%
Price Multiplier on Announcement Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 21/11/16 24/11/15 21/11/14 19/11/13 23/11/12 21/11/11 26/11/10 -
Price 2.10 2.70 3.01 2.56 2.28 2.10 2.38 -
P/RPS 1.78 1.94 2.44 2.34 2.38 2.12 2.56 -5.87%
P/EPS 17.22 13.03 12.34 11.77 12.01 10.05 11.84 6.43%
EY 5.81 7.68 8.10 8.49 8.32 9.95 8.45 -6.04%
DY 1.38 5.71 5.81 5.66 5.79 1.72 6.93 -23.56%
P/NAPS 1.30 1.68 2.23 1.98 1.88 1.79 2.22 -8.52%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment